nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—hematologic cancer—muscle cancer	0.814	1	CtDrD
Methoxsalen—CYP1A1—Dacarbazine—muscle cancer	0.0869	0.504	CbGbCtD
Methoxsalen—CYP1A2—Dacarbazine—muscle cancer	0.0388	0.225	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—muscle cancer	0.019	0.11	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—muscle cancer	0.0109	0.063	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—muscle cancer	0.00995	0.0578	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—muscle cancer	0.00679	0.0394	CbGbCtD
Methoxsalen—Folliculitis—Dactinomycin—muscle cancer	0.000646	0.0482	CcSEcCtD
Methoxsalen—Sunburn—Methotrexate—muscle cancer	0.000582	0.0435	CcSEcCtD
Methoxsalen—Leukoderma—Methotrexate—muscle cancer	0.000414	0.0309	CcSEcCtD
Methoxsalen—Leukoderma—Doxorubicin—muscle cancer	0.000358	0.0268	CcSEcCtD
Methoxsalen—Inflammation—Etoposide—muscle cancer	0.000303	0.0226	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Methotrexate—muscle cancer	0.000296	0.0221	CcSEcCtD
Methoxsalen—Skin exfoliation—Etoposide—muscle cancer	0.00028	0.0209	CcSEcCtD
Methoxsalen—Folliculitis—Methotrexate—muscle cancer	0.00028	0.0209	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.000256	0.0191	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—muscle cancer	0.000242	0.0181	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—muscle cancer	0.000226	0.0169	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—muscle cancer	0.000211	0.0158	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—muscle cancer	0.000208	0.0155	CcSEcCtD
Methoxsalen—Depression—Vincristine—muscle cancer	0.000202	0.0151	CcSEcCtD
Methoxsalen—Herpes simplex—Methotrexate—muscle cancer	0.000191	0.0143	CcSEcCtD
Methoxsalen—Inflammation—Methotrexate—muscle cancer	0.000181	0.0136	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—muscle cancer	0.000177	0.0133	CcSEcCtD
Methoxsalen—Skin exfoliation—Methotrexate—muscle cancer	0.000168	0.0125	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—muscle cancer	0.000165	0.0124	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—muscle cancer	0.000165	0.0123	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—muscle cancer	0.00016	0.012	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—muscle cancer	0.000157	0.0117	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—muscle cancer	0.000149	0.0111	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—muscle cancer	0.000145	0.0109	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—muscle cancer	0.000145	0.0108	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—muscle cancer	0.000144	0.0107	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—muscle cancer	0.000142	0.0106	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00014	0.0105	CcSEcCtD
Methoxsalen—Oedema—Vincristine—muscle cancer	0.000129	0.00966	CcSEcCtD
Methoxsalen—Infection—Vincristine—muscle cancer	0.000128	0.0096	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—muscle cancer	0.000126	0.00939	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—muscle cancer	0.000123	0.00922	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—muscle cancer	0.000121	0.00903	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—muscle cancer	0.000119	0.00891	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—muscle cancer	0.000119	0.0089	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—muscle cancer	0.000117	0.00874	CcSEcCtD
Methoxsalen—Malaise—Etoposide—muscle cancer	0.000116	0.00865	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—muscle cancer	0.000116	0.00864	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—muscle cancer	0.000115	0.00862	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—muscle cancer	0.000114	0.00855	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—muscle cancer	0.000112	0.00834	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—muscle cancer	0.000108	0.00807	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—muscle cancer	0.000107	0.00797	CcSEcCtD
Methoxsalen—Infection—Etoposide—muscle cancer	0.000104	0.00778	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—muscle cancer	0.000102	0.00764	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—muscle cancer	0.000102	0.0076	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—muscle cancer	0.000101	0.00757	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Methotrexate—muscle cancer	0.000101	0.00753	CcSEcCtD
Methoxsalen—Depression—Methotrexate—muscle cancer	9.81e-05	0.00733	CcSEcCtD
Methoxsalen—Hypotension—Etoposide—muscle cancer	9.79e-05	0.00732	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—muscle cancer	9.53e-05	0.00712	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—muscle cancer	9.13e-05	0.00682	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—muscle cancer	9.05e-05	0.00676	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—muscle cancer	8.72e-05	0.00652	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—muscle cancer	8.63e-05	0.00645	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—muscle cancer	8.6e-05	0.00643	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—muscle cancer	8.55e-05	0.00639	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—muscle cancer	8.32e-05	0.00622	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—muscle cancer	8.28e-05	0.00619	CcSEcCtD
Methoxsalen—Rash—Vincristine—muscle cancer	8.16e-05	0.00609	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—muscle cancer	8.15e-05	0.00609	CcSEcCtD
Methoxsalen—Headache—Vincristine—muscle cancer	8.1e-05	0.00605	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—muscle cancer	7.72e-05	0.00577	CcSEcCtD
Methoxsalen—Erythema—Methotrexate—muscle cancer	7.69e-05	0.00575	CcSEcCtD
Methoxsalen—Nausea—Vincristine—muscle cancer	7.68e-05	0.00574	CcSEcCtD
Methoxsalen—Dysgeusia—Methotrexate—muscle cancer	7.53e-05	0.00563	CcSEcCtD
Methoxsalen—Pruritus—Etoposide—muscle cancer	7.41e-05	0.00554	CcSEcCtD
Methoxsalen—Ill-defined disorder—Methotrexate—muscle cancer	7.13e-05	0.00533	CcSEcCtD
Methoxsalen—Malaise—Methotrexate—muscle cancer	6.93e-05	0.00518	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—muscle cancer	6.93e-05	0.00518	CcSEcCtD
Methoxsalen—Vertigo—Methotrexate—muscle cancer	6.91e-05	0.00516	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—muscle cancer	6.83e-05	0.00511	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—muscle cancer	6.66e-05	0.00498	CcSEcCtD
Methoxsalen—Rash—Etoposide—muscle cancer	6.61e-05	0.00494	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—muscle cancer	6.6e-05	0.00493	CcSEcCtD
Methoxsalen—Headache—Etoposide—muscle cancer	6.56e-05	0.0049	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—muscle cancer	6.53e-05	0.00488	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—muscle cancer	6.52e-05	0.00487	CcSEcCtD
Methoxsalen—Discomfort—Methotrexate—muscle cancer	6.47e-05	0.00483	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—muscle cancer	6.47e-05	0.00483	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—muscle cancer	6.4e-05	0.00478	CcSEcCtD
Methoxsalen—Infection—Methotrexate—muscle cancer	6.23e-05	0.00466	CcSEcCtD
Methoxsalen—Nausea—Etoposide—muscle cancer	6.22e-05	0.00465	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—muscle cancer	6.18e-05	0.00462	CcSEcCtD
Methoxsalen—Skin disorder—Methotrexate—muscle cancer	6.1e-05	0.00455	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—muscle cancer	6e-05	0.00449	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—muscle cancer	5.98e-05	0.00447	CcSEcCtD
Methoxsalen—Hypotension—Methotrexate—muscle cancer	5.86e-05	0.00438	CcSEcCtD
Methoxsalen—Insomnia—Methotrexate—muscle cancer	5.68e-05	0.00424	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—muscle cancer	5.6e-05	0.00419	CcSEcCtD
Methoxsalen—Dyspepsia—Methotrexate—muscle cancer	5.52e-05	0.00413	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—muscle cancer	5.43e-05	0.00406	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Methotrexate—muscle cancer	5.42e-05	0.00405	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—muscle cancer	5.4e-05	0.00403	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—muscle cancer	5.28e-05	0.00394	CcSEcCtD
Methoxsalen—Feeling abnormal—Methotrexate—muscle cancer	5.17e-05	0.00386	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—muscle cancer	5.08e-05	0.00379	CcSEcCtD
Methoxsalen—Urticaria—Methotrexate—muscle cancer	4.99e-05	0.00373	CcSEcCtD
Methoxsalen—Body temperature increased—Methotrexate—muscle cancer	4.96e-05	0.00371	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—muscle cancer	4.92e-05	0.00367	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—muscle cancer	4.78e-05	0.00357	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—muscle cancer	4.69e-05	0.00351	CcSEcCtD
Methoxsalen—Hypersensitivity—Methotrexate—muscle cancer	4.62e-05	0.00345	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—muscle cancer	4.48e-05	0.00335	CcSEcCtD
Methoxsalen—Pruritus—Methotrexate—muscle cancer	4.44e-05	0.00332	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—muscle cancer	4.32e-05	0.00323	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—muscle cancer	4.3e-05	0.00321	CcSEcCtD
Methoxsalen—Dizziness—Methotrexate—muscle cancer	4.15e-05	0.0031	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—muscle cancer	4e-05	0.00299	CcSEcCtD
Methoxsalen—Rash—Methotrexate—muscle cancer	3.96e-05	0.00296	CcSEcCtD
Methoxsalen—Dermatitis—Methotrexate—muscle cancer	3.95e-05	0.00295	CcSEcCtD
Methoxsalen—Headache—Methotrexate—muscle cancer	3.93e-05	0.00294	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—muscle cancer	3.84e-05	0.00287	CcSEcCtD
Methoxsalen—Nausea—Methotrexate—muscle cancer	3.73e-05	0.00279	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—muscle cancer	3.59e-05	0.00269	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—muscle cancer	3.43e-05	0.00256	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—muscle cancer	3.42e-05	0.00256	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—muscle cancer	3.4e-05	0.00254	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—muscle cancer	3.23e-05	0.00241	CcSEcCtD
